The T-maze continuous alternation task for assessing the effects of putative cognition enhancers in the mouse

Behavioural Brain Research

Volumn 151, Issue 1-2, 2004, Pages 37-46

  Spowart Manning, L ^a,c   Van Der Staay, F J ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b BAYER AG   (Germany)

^c TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Alzheimer's disease; Cholinesterase inhibitors; Mice; Spatial memory; T maze

Indexed keywords

DONEPEZIL; NOOTROPIC AGENT; SCOPOLAMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITION; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; EXPLORATORY BEHAVIOR; MALE; MAZE TEST; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; TASK PERFORMANCE;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CHOICE BEHAVIOR; CHOLINESTERASE INHIBITORS; COGNITION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; EXPLORATORY BEHAVIOR; INDANS; MAZE LEARNING; MICE; MICE, INBRED STRAINS; MUSCARINIC ANTAGONISTS; PIPERIDINES; REACTION TIME; REPRODUCIBILITY OF RESULTS; SCOPOLAMINE; SPACE PERCEPTION; SPECIES SPECIFICITY; TIME FACTORS;

EID: 16544392226     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2003.08.004     Document Type: Article

References (34)

1. Anisman H. Dissociation of disinhibitory effects of scopolamine: strain and task factors. Pharmacol. Biochem. Behav. 3:1975;613-618.
2. Bartus R.T., Dean R.L., Beer B., Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science. 217(4558):1982;408-414.
3. Bierer L., Haroutunian V., Gabriel S., Knott P.J., Carlin L.S., Purohit D.P.et al. Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J. Neurochem. 65:1995;749-760.
4. Blokland A. Acetylcholine: a neurotransmitter for learning and memory? Brain Res. Rev. 21:1995;285-300.
5. Buresova O., Bolhuis J.J., Bures J. Differential effects of cholinergic blockade on performance of rats in the water tank navigation task and in a radial water maze. Behav. Neurosci. 100:1986;476-482.
6. Decker M.W. Animal models of cognitive function. Crit. Rev. Neurobiol. 9(4):1995;321-343.
7. Egger G.J., Livesey P.J., Dawson R.G. Ontogenic aspects of central cholinergic involvement in spontaneous alternation behaviour. Dev. Psychobiol. 6:1973;289-299.
8. Festing M.F.W., Simpson E.M., Davisson M.T., Mobraaten L.E. Revised nomenclature for strain 129 mice. Mamm. Genome. 10(8):1999;836.
9. Hsiao K.K., Borchelt D.R., Olson K., Johannsdottir R., Kitt C., Yunis W.et al. Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron. 15(5):1996;1203-1218.
10. 3 antagonist thioperamide, in models of cognition and cholinergic function. Behav. Pharmacol. 7:1996;513-525.
11. Gerlai R. A new continuous alternation task in T-maze detects hippocampal dysfunction in mice. A strain comparison and lesion study. Behav. Brain Res. 95:1998;91-101.
12. Gerlai R. Gene targeting: technical confounds and potential solutions in behavioural brain research. Behav. Brain Res. 125:2001;13-21.
13. Gerlai R., Marks A., Roder J. T-maze spontaneous alternation rate is decreased in S100β transgenic mice. Behav. Neurosci. 108(1):1994;100-106.
14. Gerlai R., Thibodeaux H., Palmer J.T., van Lookeren Campagne M., Van Bruggen N. Transient focal cerebral ischemia induces sensorimotor deficits in mice. Behav. Brain Res. 108:2000;63-71.
15. Lathe R. Mice, gene targeting and behaviour: more than just genetic background. Trends Neurosci. 19:1996;183-186.
16. Meyers B., Domino E.F. The effect of cholinergic blocking drugs on spontaneous alternation in rats. Arch Int. Pharmacodyn. Ther. 150:1964;525-529.
17. Miller M.M., Hyder S.M., Assayag R., Panarell S.R., Tousignant P., Franklin K.B. Estrogen modulates spontaneous alternation and the cholinergic phenotype in the basal forebrain. Neuroscience. 91:1999;1143-1153.
18. Miner L.L. Cocaine reward and locomotor activity in C57BL/6J and 129/SvJ inbred mice and their F1 cross. Pharmacol. Biochem. Behav. 58(1):1997;25-30.
19. Molinengo L., Di Carlo G., Ghi P. Combined action of thioperamide plus scopolamine, diphenhydramine, or methysergide on memory in mice. Pharmacol. Biochem. Behav. 63(2):1999;221-227.
20. Ogura H., Kosasa T., Kuriya Y., Yamanishi Y. Donepezil, a centrally acting acetylcholinesterase inhibitor, alleviates learning deficits in hypocholinergic models in rats. Methods Find. Exp. Clin. Pharmacol. 22(2):2000;89-95.
21. Olton D.S., Samuelson R.J. Remembrance of places passed: spatial memory in rats. J. Exp. Psychol. Anim Behav. Processes. 2:1976;97-116.
22. 1 hybrids: implications of genetic background for single gene mutations and quantitative trait loci analyses. Neuroscience. 80(4):1997;1087-1099.
23. Paylor R., Crawley J.N. Inbred strain differences in prepulse inhibition of the mouse startle response. Psychopharmacology. 132:1997;169-180.
24. Royle S.J., Collins F.C., Rupniak H.T., Barnes J.C., Anderson R. Behavioural analysis and susceptibility to CNS injury of four inbred strains of mice. Brain Res. 816:1999;337-349.
25. Rush D.K. Scopolamine amnesia of passive avoidance. A deficit of information acquisition. Behav. Neural. Biol. 50:1988;255-274.
26. Sugimoto H., Yamanishi Y., Iimura Y., Kawakami Y. Donepezil hydrochloride (E2020) and other acetylcholinesterase inhibitors. Curr. Med. Chem. 7(3):2000;303-339.
27. Tolman E.C. Purpose and cognition: the determiners of animal learning. Psychol. Rev. 32:1925;285-297.
28. Ukai M., Shinkai N., Kameyama T. Cholinergic receptor antagonists inhibit pirenzepine-induced dysfunction of spontaneous alternation performance in the mouse. Gen. Pharmacol. 26:1995;1529-1532.
29. Ukai M., Shinkai N., Kameyama T. Involvement of dopamine receptors in beneficial effects of tachykinins on scopolamine-induced impairment of alternation performance in mice. Eur. J. Pharmacol. 350(1):1998;39-45.
30. 1) receptors. Brain Res. 799:1998;64-77.
31. Vanover K.E., Barrett J.E. An automated learning and memory model in mice: pharmacological and behavioural evaluation of an autoshaped response. Behav. Pharmacol. 9(3):1998;273-283.
32. Wesnes K.A., Simpson P.M., White L., Pinker S., Jertz G., Murphy M.et al. Cholinesterase inhibition in the scopolamine model of dementia. Ann. N.Y. Acad. Sci. 640:1991;268-271.
33. Willig F., Palacois A., Monmaur P., M'Harzi M., Laurent J., Delacour J. Short term memory, exploration and locomotor activity in aged rats. Neurobiol. Aging. 8:1987;393-402.
34. Zornetzer S.F., Thompson R., Rogers J. Rapid forgetting in aged rats. Behav. Neural. Biol. 36:1982;49-60.